Verrica Pharmaceuticals Announces FDA Approval of YCANTH^™ (Cantharidin) Topical Solution 0.7%

Verrica Pharmaceuticals Inc. announced FDA approval of YCANTH™ (cantharidin) topical solution for the treatment of molluscum contagiosum in adult and pediatric patients two years of age and older.